Publication | Closed Access

Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER+, and HER2− Breast Cancer

Breast OncologyHigh Ki-67MedicineReceptor Tyrosine KinaseBreast CancerCell BiologyHer2− Breast CancerCancer BiologyRadiation OncologyCell SignalingTumor BiologyEndocrine-related Cancer